Pfizer to Make $54 Billion Off Treating COVID Over and Over.

Overall, Pfizer forecasted 2022 sales of $98 billion to $102 billionPfizer is expecting record-high revenue in 2022, courtesy of COVID-19.

It’s predicting $32 billion in profits from its COVID-19 shots and another $22 billion from Paxlovid, for a total of $54 billion.

First, Pfizer profits from the shots; next, when they don’t work to prevent infection, the company makes more money by selling pills to treat the infection.

Many people experience a rebound of COVID-19 after taking Paxlovid, which means multiple courses of the drug are often necessary; this is bad news for the public but great news for Pfizer and its shareholders.

https://articles.mercola.com/sites/articles/archive/2022/09/06/pfizer-profits-from-covid.aspx?ui=ee035c6d31e79f3b1ea7e3df091d8fb6bc1d4d917ddf4a9a986631a148e2dd86&sd=20211105&cid_source=dnl&cid_medium=email&cid_content=art2HL&cid=20220906_HL2&cid=DM1254886&bid=1597097435